Classification of sleep disorders

Michael Thorpy

doi:10.1007/978-3-319-11514-6_3

Classification of sleep disorders

Michael Thorpy

Neurology

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

The International Classification of Sleep Disorders (ICSD-3) produced by the American Academy of Sleep Medicine is a major revision of the prior classification and was published in 2014. It is a major advance over previous versions but it is unfortunate that some of the diagnostic criteria differ from that of the American Psychiatric Association’s revised version of the Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-V) published in 2013 which includes a smaller section entitled “Sleep Wake Disorders.” The DSM-V serves as an entry level classification, mainly for psychiatrists, and it is to be hoped that in the future the two classifications will be merged into one that will cause less confusion not only for clinicians but also for agencies that reimburse for health care and provide for treatment options. This review discusses the main features of the diagnostic entries in the ICSD-3 and presents the pharmacological treatment focus for the disorders.

Original language	English (US)
Pages (from-to)	71-83
Number of pages	13
Journal	Milestones in Drug Therapy
Volume	49
DOIs	https://doi.org/10.1007/978-3-319-11514-6_3
State	Published - 2015

ASJC Scopus subject areas

Drug Discovery
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Access to Document

10.1007/978-3-319-11514-6_3

Cite this

@article{d47088bbabce4102a4b0c4cc2fecb8a1,

title = "Classification of sleep disorders",

abstract = "The International Classification of Sleep Disorders (ICSD-3) produced by the American Academy of Sleep Medicine is a major revision of the prior classification and was published in 2014. It is a major advance over previous versions but it is unfortunate that some of the diagnostic criteria differ from that of the American Psychiatric Association{\textquoteright}s revised version of the Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-V) published in 2013 which includes a smaller section entitled “Sleep Wake Disorders.” The DSM-V serves as an entry level classification, mainly for psychiatrists, and it is to be hoped that in the future the two classifications will be merged into one that will cause less confusion not only for clinicians but also for agencies that reimburse for health care and provide for treatment options. This review discusses the main features of the diagnostic entries in the ICSD-3 and presents the pharmacological treatment focus for the disorders.",

author = "Michael Thorpy",

note = "Publisher Copyright: {\textcopyright} 2015 Springer International Publishing Switzerland.",

year = "2015",

doi = "10.1007/978-3-319-11514-6_3",

language = "English (US)",

volume = "49",

pages = "71--83",

journal = "Milestones in Drug Therapy",

issn = "2296-6056",

publisher = "Springer Science + Business Media",

}

TY - JOUR

T1 - Classification of sleep disorders

AU - Thorpy, Michael

PY - 2015

Y1 - 2015

N2 - The International Classification of Sleep Disorders (ICSD-3) produced by the American Academy of Sleep Medicine is a major revision of the prior classification and was published in 2014. It is a major advance over previous versions but it is unfortunate that some of the diagnostic criteria differ from that of the American Psychiatric Association’s revised version of the Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-V) published in 2013 which includes a smaller section entitled “Sleep Wake Disorders.” The DSM-V serves as an entry level classification, mainly for psychiatrists, and it is to be hoped that in the future the two classifications will be merged into one that will cause less confusion not only for clinicians but also for agencies that reimburse for health care and provide for treatment options. This review discusses the main features of the diagnostic entries in the ICSD-3 and presents the pharmacological treatment focus for the disorders.

AB - The International Classification of Sleep Disorders (ICSD-3) produced by the American Academy of Sleep Medicine is a major revision of the prior classification and was published in 2014. It is a major advance over previous versions but it is unfortunate that some of the diagnostic criteria differ from that of the American Psychiatric Association’s revised version of the Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-V) published in 2013 which includes a smaller section entitled “Sleep Wake Disorders.” The DSM-V serves as an entry level classification, mainly for psychiatrists, and it is to be hoped that in the future the two classifications will be merged into one that will cause less confusion not only for clinicians but also for agencies that reimburse for health care and provide for treatment options. This review discusses the main features of the diagnostic entries in the ICSD-3 and presents the pharmacological treatment focus for the disorders.

UR - http://www.scopus.com/inward/record.url?scp=84921415553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921415553&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-11514-6_3

DO - 10.1007/978-3-319-11514-6_3

M3 - Article

AN - SCOPUS:84921415553

SN - 2296-6056

VL - 49

SP - 71

EP - 83

JO - Milestones in Drug Therapy

JF - Milestones in Drug Therapy

ER -

Classification of sleep disorders

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this